Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1242 (LINC01242)

Target
LINC01242
Molecular classification
Long non-coding RNA (lncRNA), Intergenic non-coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 1242 (LINC01242) is a human gene encoding a long, non-coding RNA transcript that does not overlap any protein-coding genes[1][3][5]. LINC01242 is part of a class of regulatory RNA molecules known as lncRNAs, which have been implicated in diverse cellular functions—including regulation of neighboring gene expression, modulation of transcriptional programs, and epigenetic control[5][7]. Although most lncRNAs remain poorly understood, high-throughput genomics suggests potential roles in cell cycle regulation and cancer[2][7]. To date, LINC01242 has not been validated as a direct therapeutic target, nor does it have any approved drugs acting upon it. Its primary relevance is in research and possibly as a biomarker in gene expression profiling for diseases like cancer[2].

Other names
LINC01242Long intergenic non-protein coding RNA 1242
02

Mechanism of action

Not applicable; no drugs directly target this molecule. RNA molecules like lincRNAs are sometimes indirectly modulated by epigenetic drugs or transcriptional therapies, but no specifics for LINC01242.

03

Biological functions

May be involved in gene expression regulationSome lincRNAs similar to LINC01242 have been associated with regulation of cell cycle, cell size, and chromatin-mediated processesPossible function in regulation of adjacent gene expression or modulation of transcriptional programsPrecise biological role of LINC01242 remains poorly characterized; most lincRNAs act as regulators rather than effectors.
04

Disease associations

There is evidence linking some lincRNAs (including possible relatives of LINC01242) with cancer, particularly acute myeloid leukemia (AML), based on transcriptomic association studiesNo direct evidence yet of causality or mechanistic involvement for LINC01242 specificallyOther (pending further research)
05

Safety considerations

As an endogenous RNA without existing targeted agents, there are no direct safety concerns or therapeutic challenges identified for LINC01242In general, targeting lncRNAs can present delivery and specificity challenges
06

Interacting drugs

No drugs are currently known to directly interact with LINC01242, as it is an RNA molecule and not a classical druggable target

1 more in the full profile.

07

Biomarkers

LINC01242 and similar lincRNAs may be considered as potential biomarkers for disease states, especially where expression level changes are observed in cancer transcriptomics studiesNo specific validated use as a biomarker yet for LINC01242

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1242 (LINC01242).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1242 (LINC01242).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call